NO996520D0 - Opploeste sertralinblandinger - Google Patents

Opploeste sertralinblandinger

Info

Publication number
NO996520D0
NO996520D0 NO996520A NO996520A NO996520D0 NO 996520 D0 NO996520 D0 NO 996520D0 NO 996520 A NO996520 A NO 996520A NO 996520 A NO996520 A NO 996520A NO 996520 D0 NO996520 D0 NO 996520D0
Authority
NO
Norway
Prior art keywords
mixtures
dissolved sertraline
sertraline
dissolved
sertraline mixtures
Prior art date
Application number
NO996520A
Other languages
English (en)
Other versions
NO996520L (no
Inventor
Dwayne Thomas Friesen
Scott Max Herbig
Ravi Mysore Shanker
James Blair West
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996520(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO996520D0 publication Critical patent/NO996520D0/no
Publication of NO996520L publication Critical patent/NO996520L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO996520A 1997-07-01 1999-12-28 Oppløste sertralinblandinger NO996520L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
NO996520D0 true NO996520D0 (no) 1999-12-28
NO996520L NO996520L (no) 2000-02-29

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996520A NO996520L (no) 1997-07-01 1999-12-28 Oppløste sertralinblandinger

Country Status (34)

Country Link
EP (1) EP0999829A1 (no)
JP (1) JP2000514100A (no)
KR (1) KR100366373B1 (no)
CN (1) CN1261794A (no)
AP (1) AP1192A (no)
AR (3) AR015917A1 (no)
AU (1) AU742535B2 (no)
BG (1) BG103918A (no)
BR (1) BR9810739A (no)
CA (1) CA2290974C (no)
CO (1) CO4940495A1 (no)
DZ (1) DZ2548A1 (no)
EA (1) EA002481B1 (no)
HN (1) HN1998000102A (no)
HR (1) HRP980377A2 (no)
HU (1) HUP0002236A3 (no)
ID (1) ID23429A (no)
IL (1) IL133076A (no)
IS (1) IS5260A (no)
MA (1) MA24587A1 (no)
NO (1) NO996520L (no)
OA (1) OA11243A (no)
PA (1) PA8454301A1 (no)
PE (1) PE97199A1 (no)
PL (1) PL337804A1 (no)
SK (1) SK181099A3 (no)
TN (1) TNSN98124A1 (no)
TR (1) TR199903297T2 (no)
TW (1) TW550087B (no)
UA (1) UA67741C2 (no)
UY (1) UY25071A1 (no)
WO (1) WO1999001120A1 (no)
YU (1) YU68299A (no)
ZA (1) ZA985708B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
JPWO2011081117A1 (ja) * 2009-12-29 2013-05-09 興和株式会社 経口投与用固形医薬組成物
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
CN1261794A (zh) 2000-08-02
KR20010013365A (ko) 2001-02-26
HUP0002236A2 (hu) 2003-08-28
CO4940495A1 (es) 2000-07-24
TW550087B (en) 2003-09-01
PA8454301A1 (es) 2000-09-29
UY25071A1 (es) 2000-12-29
IL133076A0 (en) 2001-03-19
EA002481B1 (ru) 2002-06-27
BG103918A (en) 2000-07-31
JP2000514100A (ja) 2000-10-24
AR015917A1 (es) 2001-05-30
UA67741C2 (uk) 2004-07-15
AR040280A2 (es) 2005-03-23
HUP0002236A3 (en) 2003-12-29
HN1998000102A (es) 1999-01-08
AU7544898A (en) 1999-01-25
EA199900962A1 (ru) 2000-08-28
OA11243A (en) 2003-07-24
DZ2548A1 (fr) 2003-02-08
IL133076A (en) 2003-12-10
TR199903297T2 (xx) 2000-07-21
PE97199A1 (es) 1999-10-05
PL337804A1 (en) 2000-09-11
SK181099A3 (en) 2000-07-11
CA2290974A1 (en) 1999-01-14
EP0999829A1 (en) 2000-05-17
CA2290974C (en) 2004-04-27
AP1192A (en) 2003-07-23
WO1999001120A1 (en) 1999-01-14
ZA985708B (en) 2000-01-10
MA24587A1 (fr) 1998-12-31
TNSN98124A1 (fr) 2005-03-15
HRP980377A2 (en) 1999-04-30
IS5260A (is) 1999-11-19
BR9810739A (pt) 2000-09-12
AR040279A2 (es) 2005-03-23
KR100366373B1 (ko) 2003-01-14
YU68299A (sh) 2002-06-19
AP9801280A0 (en) 1998-06-30
AU742535B2 (en) 2002-01-03
NO996520L (no) 2000-02-29
ID23429A (id) 2000-04-20

Similar Documents

Publication Publication Date Title
NO985337D0 (no) Tetrahydrolipstatin-holdige blandinger
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
DE69711357D1 (de) Bodenbelüfter
DE59808569D1 (de) Fräsbrecherfahrzeug
NO993753L (no) Esterpolymerdispersjon
PT1036083E (pt) Novos 9a-azalidos
ID23497A (id) Kombinasi pembungkus-deterjen
IS5445A (is) Statín-karboxýalkýleter-blöndur
FI974503A0 (fi) Medicinsk avbildningsanordning
NO995147D0 (no) Kontrastmidler
BR9801805A (pt) Dioxacicloalcan-8-ona
NO996520D0 (no) Opploeste sertralinblandinger
DE59806387D1 (de) Azofarbstoffmischungen
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
ATA111897A (de) Kimme
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE29710013U1 (de) Rührwerk
ATA86797A (de) Verschleissschuh
NO981152D0 (no) Romoppvarmingsenhet
ATA46498A (de) Kunststoffgleitbahn
NO974138D0 (no) Kontrastmidler
DE29707615U1 (de) Rührwerk
KR980004492U (ko) 막대자

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application